Exelixis Inc (EXEL) 11.15 $EXEL Exelixis to Present at

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 1:00 AM

Exelixis Inc (EXEL) 11.15 $EXEL

Exelixis to Present at the Morgan Stanley Global Healthcare Conference on September 13
BusinessWire - Wed Aug 31, 3:17PM CDT
Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company's president and chief executive officer, will provide an overview of the company at the Morgan Stanley Global Healthcare Conference taking place September 12-14 in New York, NY. The Exelixis presentation is scheduled for 9:10 AM EDT/6:10 AM PDT on Tuesday, September 13, 2016.
EXEL: 11.15 (+0.11), MS: 32.06 (-0.13)

Exelixis-discovered Compounds To Be Featured in 15 Presentations at the ESMO 2016 Congress
BusinessWire - Wed Aug 31, 7:30AM CDT
Exelixis, Inc. (NASDAQ:EXEL) today announced that data from clinical trials of cabozantinib and cobimetinib will be the subject of 15 presentations at the European Society for Medical Oncology (ESMO) 2016 Congress in Copenhagen, October 7 - 11, 2016.
EXEL: 11.15 (+0.11)

Kinder Morgan trade offers a 6% return in 108 days, or find similar option trades on Amazon.com, Alleghany Technologies, Boeing, and Exelixis
PR Newswire - Tue Aug 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AMZN, ATI, BA, EXEL, and KMI.
KMI: 21.85 (-0.06), AMZN: 769.16 (+1.58), ATI: 17.06 (-0.54), BA: 129.45 (-1.36), EXEL: 11.15 (+0.11)

Why Exelixis (EXEL) Could Be Positioned for a Surge
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 8:00AM CDT
Exelixis (EXEL) has decent short-term momentum and it is seeing solid activity on the earnings estimate revision front too.
EXEL: 11.15 (+0.11)

Exelixis Announces Redemption of All Remaining 4.25% Convertible Senior Subordinated Notes Due 2019
BusinessWire - Wed Aug 24, 7:30AM CDT
Exelixis, Inc. (NASDAQ:EXEL) today announced that it has called for redemption approximately $48.1 million of its 4.25% Convertible Senior Subordinated Notes due 2019, representing all remaining notes outstanding. The redemption will be made in accordance with the terms of the indenture governing the notes and the terms of the redemption notice.
EXEL: 11.15 (+0.11)

Learn how to target a 20% return on Valeant Pharmaceuticals, or get option-trade ideas on Acacia Communications, Radius Health, General Electric and Exelixis or any stock you choose
PR Newswire - Mon Aug 15, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACIA, EXEL, GE, RDUS, and VRX.
RDUS: 54.84 (-0.67), VRX: 29.03 (-1.22), GE: 31.24 (-0.13), ACIA: 111.65 (-2.92), EXEL: 11.15 (+0.11)

Covered Call reports for Valeant Pharmaceuticals, Merrimack Pharmaceuticals, Exelixis, Under Armour and Harman International Industries include trade ideas that offer returns of 20% or more!
PR Newswire - Fri Aug 05, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for EXEL, HAR, MACK, UA, and VRX.
MACK: 4.62 (-0.06), UA: 39.63 (-1.93), VRX: 29.03 (-1.22), HAR: 84.69 (-0.26), EXEL: 11.15 (+0.11)

Exelixis (EXEL) Posts Narrower Loss in Q2, Beats on Revenues
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 2:52PM CDT
Exelixis, Inc. (EXEL) posted a second-quarter 2016 loss of 16 cents, narrower than both the Zacks Consensus Estimate of 27 cents and the year-ago loss of 22 cents
BIIB: 305.63 (-2.23), EXEL: 11.15 (+0.11)

Look for Shares of Exelixis to Potentially Pullback after Yesterday's 20.45% Rise
Comtex SmarTrend(R) - Thu Aug 04, 12:20PM CDT
Exelixis (NASDAQ:EXEL) traded in a range yesterday that spanned from a low of $10.02 to a high of $11.66. Yesterday, the shares gained 20.4%, which took the trading range above the 3-day high of $9.40 on volume of 15.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EXEL: 11.15 (+0.11)

Correction: Earns-Exelixis story
AP - Thu Aug 04, 10:16AM CDT
SOUTH SAN FRANCISCO, Calif. (AP) — In a story August 4 about Exelixis Inc.'s quarterly results — generated by Automated Insights using data from Zacks Investment Research — The Associated Press reported erroneously that the company is forecasting annual revenue of $250 million to $270 million. Exelixis projects full-year operating expenses of $250 million to $270 million.
EXEL: 11.15 (+0.11)

Exelixis Announces Second Quarter and Year to Date 2016 Financial Results and Provides Corporate Update
BusinessWire - Wed Aug 03, 3:17PM CDT
--- Conference Call and Webcast Today at 5:00 PM Eastern Time -
EXEL: 11.15 (+0.11)

Parker-Hannifin (PH) Q4 Earnings: Disappointment in Store?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 5:33PM CDT
Leading manufacturer of motion & control technologies and systems, Parker-Hannifin Corporation (PH), is slated to report fourth-quarter fiscal 2016 results on Aug 4, before the opening bell.
HSC: 9.95 (-0.10), IPXL: 24.19 (-0.23), PH: 122.53 (-0.67), EXEL: 11.15 (+0.11)

Exelixis Shares Up 83.5% Since SmarTrend's Buy Recommendation (EXEL)
Comtex SmarTrend(R) - Tue Aug 02, 12:41PM CDT
SmarTrend identified an Uptrend for Exelixis (NASDAQ:EXEL) on April 26th, 2016 at $4.92. In approximately 3 months, Exelixis has returned 83.54% as of today's recent price of $9.03.
EXEL: 11.15 (+0.11)

Can GW Pharmaceuticals (GWPH) Surprise in Q3 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 10:26AM CDT
GW Pharmaceuticals (GWPH), which is is set to report third-quarter fiscal 2016 results on Aug 4, had posted a positive surprise of 35.67% last quarter.
BMRN: 93.89 (-1.06), GWPH: 81.75 (-0.02), ICPT: 148.31 (-2.36), EXEL: 11.15 (+0.11)

Will Agios (AGIO) Disappoint Estimates in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 10:23AM CDT
Agios Pharmaceuticals (AGIO), which is set to report second-quarter 2016 results on Aug 4, had posted a positive surprise of 11.59% last quarter.
ICPT: 148.31 (-2.36), AGIO: 36.84 (+0.22), EXEL: 11.15 (+0.11), CELG: 106.74 (-0.28)

Drug Stocks to Watch for Earnings on Aug 3: ZTS, EXEL & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:30AM CDT
Can drug stocks Zoetis, Conatus and others pull a surprise when they report their Q2 results on Aug 3?
ZTS: 51.10 (+0.35), JNJ: 119.34 (-0.13), GILD: 78.38 (+0.46), GERN: 2.69 (unch), CNAT: 1.81 (-0.07), AERI: 19.36 (-0.06), EXEL: 11.15 (+0.11)

Fluor (FLR) Q2 Earnings: Disappointment in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:20AM CDT
Fluor Corporation (FLR) is set to report second-quarter 2016 results, after the closing bell on Aug 4.
HSC: 9.95 (-0.10), IPXL: 24.19 (-0.23), FLR: 51.90 (-0.69), EXEL: 11.15 (+0.11)

What Awaits Aerie Pharmaceuticals (AERI) in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 5:38PM CDT
Aerie Pharmaceuticals, Inc. (AERI) is scheduled to report second-quarter 2016 results after the market closes on Aug 3.
IPXL: 24.19 (-0.23), IRWD: 13.34 (-0.08), AERI: 19.36 (-0.06), EXEL: 11.15 (+0.11)

Merrimack (MACK): Can the Stock Surprise in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 5:38PM CDT
Merrimack (MACK) is scheduled to report second-quarter 2016 results on Aug 4.
MACK: 4.62 (-0.06), IRWD: 13.34 (-0.08), LLY: 77.75 (-0.02), EXEL: 11.15 (+0.11)

Conatus (CNAT) May Surprise in Q2 Earnings: Stock to Gain?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 5:36PM CDT
Conatus (CNAT), which is set to report second-quarter 2016 results on Aug 3, posted in-line results last quarter. Will the stock pull a surprise this quarter?
BMRN: 93.89 (-1.06), CNAT: 1.81 (-0.07), ICPT: 148.31 (-2.36), EXEL: 11.15 (+0.11)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Karen Love's Retirement Marks End of an Era for TACHP

A Legacy Not Just Built, But Carved in Stone In the world of healthcare, folks like Karen Love don’t come around too often. She's stepping down from her post as President and CEO of Cook Children's Health Plan this month, and it feels like the end of a chapter for the Texas Association of Community Health Plans (TACHP). Love wasn't just an executive; she was a mover and...

MiniCo's New Desk: A Game Changer for E&S Market

A New Chapter in Industrial Casualty Look out, folks! MiniCo Insurance Agency is making waves with its latest launch. They're teaming up with Lloyd's of London, not to sell fish and chips, but to bring something groundbreaking in the insurance space—an industrial casualty trading desk. And if you’re raising an eyebrow wondering why this matters, let me break it down...

Rochester Memorial Installations: Key Timelines Revealed

There are times in life where patience isn’t just a virtue, it’s a necessity—memorial installations are one of those instances. In Rochester, NY, folks dealing with the loss of a loved one want more than just closures; they want to commemorate their people in a way that lasts. But how long does it take, really, to set these tributes in stone? Understanding the...

New Tools Arm Manufacturers in Additive Arena

Diving Headfirst into Additive Manufacturing Standards Additive manufacturing (AM)—it's not just another tech buzzword. It's revolutionizing everything from life-saving medical devices to cutting-edge aerospace components. But as with any game-changing innovation, there's a wild west era before standards reign in the chaos. Enter ANSI and America Makes, offering new...

Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...

Athlete Threats: Public Info Fuels Security Risks

Public Exposure: The New Athlete Achilles' Heel Imagine sitting on millions while living in a glass house. That's the kind of predicament today's athletes find themselves in, thanks to the treasure trove of public information spilling their personal lives all over the internet. According to the latest Hush Intelligence Athlete Threat Report 2026, this very exposure has...

Ace Hardware Ups the Stakes with Rewards Days Event

Ace Hardware: Doubling Down with Rewards Ace Hardware's rolling out the red carpet for its loyal customers. Imagine this: exclusive deals on trusted brands and double points on purchases—an incentive any savvy shopper would jump at. From October 6 to 7, those in the Ace Rewards circle have the chance to nab some hefty savings and perks, a move that's more than just a...

Gateway Unveils All-In-One Award Travel Platform

Transforming Loyalty with point.me's Gateway Here's the deal: the loyalty program game just changed. Point.me rolled out this slick beast called Gateway, and it's weaving award travel booking right into your everyday banking apps. That's right, ditch those clunky third-party sites, because now you can browse, compare, transfer, and book your award travel directly from...

Neutonic Sets Sights on U.S. with Walmart Expansion

Neutonic Embarks on Major Expansion with Walmart Well, here we go. Neutonic is stepping up to the big leagues by planting its flag in nearly 1,000 Walmart stores across the U.S. This move lands them right in the thrumming heart of Walmart's new Mood & Mind beverage set. It's about time this brand brings its functional beverages to American shoppers already drained by...

Texas A&M-San Antonio's Research Expansion Momentum

Texas A&M-San Antonio's Rising Research Ambitions A rainy day in San Antonio and Texas A&M University-San Antonio seems to have set the stage for more than just another semester of record enrollment. They’ve just rolled in with an exhilarating $8 million in external grants this fiscal year, more than doubling last year’s haul of $3.6 million, in a bid to push their...